3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Other
1
Gynecologic
1
Gastrointestinal
1
Conditions
Weight Loss
1
Ovarian Neoplasms
1
Obesity
1
Malnutrition
1
Gastrointestinal Neoplasms
1
Endometrial Neoplasms
1
Interventions
pembrolizumab
1258
Specimen Handling
864
Carboplatin
824
Magnetic Resonance Spectroscopy
806
Cyclophosphamide
798
Cisplatin
719
Nivolumab
660
Paclitaxel
635
Gemcitabine
570
Radiotherapy
570
Biopsy
526
Bevacizumab
467
Dexamethasone
441
fludarabine
403
Docetaxel
375
venetoclax
369
Oxaliplatin
363
Capecitabine
355
Fluorouracil
354
atezolizumab
337
Rituximab
333
durvalumab
332
Doxorubicin
316
Pemetrexed
306
Radiosurgery
304
Drug Therapy
300
Ipilimumab
296
Standard of Care
288
Etoposide
283
Radiation
277
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Sampling Studies
×
1 year
×
Clear all
NCT02573974
2025-12-22
METERMUCADIG
University Hospital, Tours
Phase NA
Completed
51 enrolled
NCT03027479
2025-12-22
METERMUS-IMC
University Hospital, Tours
Phase NA
Completed
70 enrolled